DEEP BIO
Deep Bio is a medical AI startup that aims to revolutionize cancer diagnosis. Deep Bio combines cutting-edge AI algorithms with digital pathology to empower pathologists and streamline existing workflows.
DEEP BIO
Industry:
Artificial Intelligence Biotechnology Health Diagnostics Medical Software
Founded:
2015-10-08
Address:
Seoul, Seoul-t'ukpyolsi, South Korea
Country:
South Korea
Website Url:
http://www.deepbio.co.kr
Total Employee:
11+
Status:
Active
Total Funding:
0
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Font Awesome Apache Mobile Non Scaleable Content Euro Amazon Google Apps For Business PHP
Current Employees Featured
Founder
Official Site Inspections
http://www.deepbio.co.kr Semrush global rank: 6.12 M Semrush visits lastest month: 1.32 K
- Host name: ec2-13-125-156-192.ap-northeast-2.compute.amazonaws.com
- IP address: 13.125.156.192
- Location: Incheon South Korea
- Latitude: 37.4562
- Longitude: 126.7288
- Timezone: Asia/Seoul
- Postal: 21539
More informations about "Deep Bio"
About – Deep Bio
DeepDx ® Prostate is a clinically-validated AI solution for prostate core needle biopsy tissue image analysis. Whole-slide images (WSIs) of H&E-stained biopsy tissue specimens are …See details»
Deep Bio - Crunchbase Company Profile & Funding
Contact Email [email protected] Deep Bio is a medical AI startup that aims to revolutionize cancer diagnosis. Deep Bio combines cutting-edge AI algorithms with digital pathology to …See details»
Deep Bio Inc. | LinkedIn
Www.deepbio.co.kr External link for Deep Bio Inc. Industry Software Development Company size 11-50 employees ... #TeamBonding #CultureDay #DeepBio #BusinessDevelopment #CreativitySee details»
deep bio
Deep Bio Inc. will be attending Digital Pathology & AI Congress: Europe! We invite you to our booth #32 to talk about innovations in digital pathology and introduce Deep Bio’s newest …See details»
Deep Bio Earns Coveted Spot in Korea AI Startup 100 List for the …
Oct 9, 2023 On the global stage, Deep Bio is strategically expanding its footprint through partnerships with digital pathology platform providers across the United States, Europe, and …See details»
Deep Bio Company Profile 2024: Valuation, Funding
Publication ID Patent Title Status First Filing Date Technology (CPC) Citations; EP-4432301-A1: Method for training artificial neural network providing determination result of pathology specimen, and computing system performing …See details»
Deep Bio Super Gap Startup 1000+ | Tissuepathology.com
Aug 7, 2023 SEOUL, SOUTH KOREA (PRWEB) JULY 07, 2023 – Deep Bio Inc., a leader in artificial intelligence (AI)-powered cancer diagnostics, has been selected for the South Korean …See details»
Deep Bio’s AI Support for Cancer Diagnosis has been Designated …
Jul 26, 2022 SEOUL, SOUTH KOREA (PRWEB) JULY 25, 2022 Deep Bio, a pioneer in medical AI for digital pathology and cancer diagnostics software, announced that its AI solution for …See details»
Deep Bio and ARUP to Evaluate AI Performance in a ... - ARUP …
Oct 24, 2021 Deep Bio is actively engaged in the research space and maintains ongoing collaborations with top U.S. medical centers. To learn more, visit www.deepbio.co.kr. DeepDx …See details»
Deep Bio Secures Spot in South Korean Government’s Prestigious …
DeepBio, ‘prostate cancer’ detection using AI ..closes seed rounding. Deep Bio, is a start-up company that develops artificial intelligence (AI) to diagnose prostate cancer. There are …See details»
Deep Bio Joins CancerX to Revolutionize Cancer Diagnosis and …
Nov 9, 2023 For more information about Deep Bio, please visit www.deepbio.co.kr or contact [email protected]. About Deep Bio. Deep Bio is an AI healthcare company dedicated to …See details»
Deep Bio Innovative Product Korean PPS | Tissuepathology.com
Jul 26, 2022 Deep Bio: This designation marks the Korean government’s recognition of innovation for DeepDx®-Prostate Pro. SEOUL, SOUTH KOREA (PRWEB) JULY 25, 2022 …See details»
DeepBio cancer AI CES Innovation Award | Tissuepathology.com
Nov 29, 2023 DeepBio won the CES Innovation Award for pioneering a new milestone in Korean cancer diagnosis A.I. solutions. SEOUL, South Korea , Nov. 20, 2023 /PRNewswire/ — …See details»
Deep Bio’s Novel Study Results Reaffirm Its Global Presence
Mar 16, 2023 SEOUL, SOUTH KOREA (PRWEB) MARCH 14, 2023. Deep Bio, a pioneer in medical AI for digital pathology and cancer diagnostics support software shared three research …See details»
Deep Bio Joins CancerX to Revolutionize Cancer Diagnosis and …
Nov 7, 2023 For more information about Deep Bio, please visit www.deepbio.co.kr or contact [email protected]. About Deep Bio. Deep Bio is an AI healthcare company dedicated to …See details»
DeepBio becomes first Korean cancer diagnostic A.I. company to …
Nov 20, 2023 DeepBio recognizes this award as an achievement that demonstrates its world-class technology in cancer diagnosis and prognosis and raises the profile of Korean cancer …See details»
Deep Bio Reaffirms Global Presence | Tissuepathology.com
Mar 28, 2023 SEOUL, SOUTH KOREA (PRWEB) MARCH 14, 2023 – Deep Bio, a pioneer in medical AI for digital pathology and cancer diagnostics support software shared three research …See details»
DeepBio becomes first Korean cancer diagnostic A.I. company to …
Nov 20, 2023 -Won the CES Innovation Award for pioneering a new milestone in Korean cancer diagnosis A.I. solutions. SEOUL, South Korea, Nov. 20, 2023 /PRNewswire/ -- DeepBio …See details»
DeepBio Wins The CES Innovation Award For Pioneering, A New …
Nov 27, 2023 DeepBio won the CES Innovation Award for pioneering a new milestone in Korean cancer diagnosis A.I. solutions. DeepBio has announced that it has been awarded the CES …See details»